Skip to content
Wednesday, November 11, 2026
HubSpark Magazine

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Deal Over Data Concerns

Health aid illustration
The proposed US financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) spanning five years due to Washington's demand for confidential information.

The decision came to light after a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesperson has since explained that the US was seeking health data for scientific study and profit but was unwilling to share the resulting advantages from any future treatments.

"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for further dialogue to find a deal suitable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Context

This rejection comes after a comparable situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.

According to statements, Sixteen nations in Africa have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Our nation was requested to provide its genetic material and health information for a long time, without any corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," he stated.

"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our population should a new pandemic emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were upending frameworks previously established via the international organization.

Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage future pandemics.

"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."

These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to further discussions with our US partners on how future co-operation might be designed in a manner that honours the sovereignty and interests of both nations."

Medical Community Reaction

Medical experts stated it acknowledged the official position, but suggested that negotiations should continue given that much of the country's Aids initiatives relied on external financing.

"If specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.

The situation emphasises the complex challenges between receiving vital international aid and protecting a country's data in an increasingly data-driven world.

About the author

James Robbins

Elena Voss is a digital marketing strategist and freelance writer passionate about helping brands find their unique voice.

HubSpark Magazine

Type to search articles.